Application
Fig1: Western blot analysis of PPP1CB on human PPP1CB recombinant protein using anti-PPP1CB antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of PPP1CB on HEK293 (1) and PPP1CB-hIgGFc transfected HEK293 (2) cell lysate using anti-PPP1CB antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of PPP1CB on different cell lysate using anti-PPP1CB antibody at 1/1,000 dilution. Positive control: Line1: Jurkat Line2: A431 Line3: Hela Line4: HepG2 Line5: HEK293 Line6: MCF-7
Application
Fig4: ICC staining PPP1CB (green) in MCF-7 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-PPP1CB antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissue using anti-PPP1CB antibody. Counter stained with hematoxylin.
Application
Fig7: Flow cytometric analysis of Hela cells with PPP1CB antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).